Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Online

Basic Safety Sciences: Pharmacoepidemiology, Clinical Pharmacology, Pharmacogenomics, and Toxicology Studies

Learn the principles of safety sciences including toxicology, clinical pharmacology, pharmacogenomics, and pharmacoepidemiology in order to analyze potential safety issues.

Overview

This eLearning course reviews the principles of safety sciences including toxicology, clinical pharmacology, pharmacogenomics, and pharmacoepidemiology to enable you to analyze potential safety issues, and to better understand the patient population and its experience with the drug. The course will walk learners through activities and associated competencies needed to advance a drug candidate from an idea in a lab to a treatment ready to be studied in humans. Keep in mind that the application of these sciences to safety and pharmacovigilance continue to change as the environment, regulations, and guidance for drug development continue to evolve.

The module takes an average of 7 hours to complete.

This eLearning module can be purchased individually or as part of the Drug Safety eLearning Bundle (7 modules).

Featured topics

    • Toxicology
    • Clinical pharmacology
    • Pharmacogenomics
    • Pharmacoepidemiology

Who should attend?

  • This module is designed for professionals working in:

    • Drug safety and pharmacovigilance
    • Clinical research and development
    • Quality assurance and compliance
    • Regulatory affairs
    • Medical affairs
    • Medical writing

      Learning objectives

      • Upon completion of this course, learners should be able to:

        • Identify the basics of toxicology studies
        • Recognize the limitations in predicting human toxicity
        • Outline the basic principles of clinical pharmacology
        • Recognize the fundamentals of pharmacogenomics
        • Utilize the principles of pharmacoepidemiology and other drug safety sciences to analyze potential safety issues
        • Classify the patient population using the principles of pharmacoepidemiology and other drug safety sciences

      Have an account?

      Be informed and stay engaged.

      Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.